MBBS · Pharmacology

Unit 7: Antibacterial Drugs MCQs

60 solved multiple choice questions with answers and short explanations.

Q1. Which mechanism best explains the principal pharmacologic action of Penicillin G?

  1. Abinds penicillin-binding proteins and inhibits peptidoglycan cross-linking
  2. Binhibits bacterial cell-wall synthesis as an aminopenicillin
  3. Cinhibits bacterial cell-wall synthesis as a third-generation cephalosporin
  4. Dbinds PBPs of aerobic gram-negative bacteria as a monobactam
Show answer
Answer: A. binds penicillin-binding proteins and inhibits peptidoglycan cross-linkingPenicillin G binds penicillin-binding proteins and inhibits peptidoglycan cross-linking. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q2. Which clinical use is most appropriately associated with Penicillin G?

  1. Abroad empiric treatment of serious polymicrobial infections
  2. Bsusceptible streptococcal and spirochetal infections
  3. Cserious gram-positive infections including MRSA
  4. Dserious aerobic gram-negative infections and selected synergistic regimens
Show answer
Answer: B. susceptible streptococcal and spirochetal infectionsPenicillin G is used for susceptible streptococcal and spirochetal infections. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q3. Which adverse effect or toxicity is particularly important to recognize with Penicillin G?

  1. Anephrotoxicity and infusion-related flushing
  2. Brash, diarrhea, and hypersensitivity
  3. Chypersensitivity reactions and seizures at very high exposure
  4. Dseizures are uncommon but possible, especially with predisposition
Show answer
Answer: C. hypersensitivity reactions and seizures at very high exposureAn important safety issue with Penicillin G is hypersensitivity reactions and seizures at very high exposure. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q4. A drug binds penicillin-binding proteins and inhibits peptidoglycan cross-linking and is used for susceptible streptococcal and spirochetal infections. Which drug best matches this description?

  1. ADoxycycline
  2. BAmoxicillin
  3. CAztreonam
  4. DPenicillin G
Show answer
Answer: D. Penicillin GThe description matches Penicillin G: it binds penicillin-binding proteins and inhibits peptidoglycan cross-linking and is used for susceptible streptococcal and spirochetal infections.
Report a mistake

Q5. Which mechanism best explains the principal pharmacologic action of Amoxicillin?

  1. Ainhibits bacterial cell-wall synthesis as an aminopenicillin
  2. Bcombines an antipseudomonal penicillin with a beta-lactamase inhibitor
  3. Cbinds D-Ala-D-Ala termini and inhibits cell-wall synthesis
  4. Dinhibits bacterial cell-wall synthesis as a carbapenem
Show answer
Answer: A. inhibits bacterial cell-wall synthesis as an aminopenicillinAmoxicillin inhibits bacterial cell-wall synthesis as an aminopenicillin. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q6. Which clinical use is most appropriately associated with Amoxicillin?

  1. Ameningitis, gonorrhea, and other susceptible infections
  2. Bsusceptible respiratory and other community infections
  3. Cselected gram-negative infections in patients with severe beta-lactam allergy
  4. Drickettsial, chlamydial, atypical, and tick-borne infections
Show answer
Answer: B. susceptible respiratory and other community infectionsAmoxicillin is used for susceptible respiratory and other community infections. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q7. Which adverse effect or toxicity is particularly important to recognize with Amoxicillin?

  1. AGI effects and liver-enzyme elevations
  2. Bhypersensitivity, cytopenias, and renal dosing concerns
  3. Crash, diarrhea, and hypersensitivity
  4. Dnephrotoxicity and ototoxicity
Show answer
Answer: C. rash, diarrhea, and hypersensitivityAn important safety issue with Amoxicillin is rash, diarrhea, and hypersensitivity. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q8. A drug inhibits bacterial cell-wall synthesis as an aminopenicillin and is used for susceptible respiratory and other community infections. Which drug best matches this description?

  1. AAzithromycin
  2. BPiperacillin-tazobactam
  3. CMeropenem
  4. DAmoxicillin
Show answer
Answer: D. AmoxicillinThe description matches Amoxicillin: it inhibits bacterial cell-wall synthesis as an aminopenicillin and is used for susceptible respiratory and other community infections.
Report a mistake

Q9. Which mechanism best explains the principal pharmacologic action of Piperacillin-tazobactam?

  1. Acombines an antipseudomonal penicillin with a beta-lactamase inhibitor
  2. Binhibits bacterial cell-wall synthesis as a third-generation cephalosporin
  3. Cbinds PBPs of aerobic gram-negative bacteria as a monobactam
  4. Dirreversibly binds the bacterial 30S ribosomal subunit
Show answer
Answer: A. combines an antipseudomonal penicillin with a beta-lactamase inhibitorPiperacillin-tazobactam combines an antipseudomonal penicillin with a beta-lactamase inhibitor. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q10. Which clinical use is most appropriately associated with Piperacillin-tazobactam?

  1. Aserious gram-positive infections including MRSA
  2. Bbroad empiric treatment of serious polymicrobial infections
  3. Cserious broad-spectrum infections
  4. Datypical respiratory infections and selected sexually transmitted infections
Show answer
Answer: B. broad empiric treatment of serious polymicrobial infectionsPiperacillin-tazobactam is used for broad empiric treatment of serious polymicrobial infections. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q11. Which adverse effect or toxicity is particularly important to recognize with Piperacillin-tazobactam?

  1. Aseizures are uncommon but possible, especially with predisposition
  2. Bbiliary sludging and hypersensitivity
  3. Chypersensitivity, cytopenias, and renal dosing concerns
  4. Dphotosensitivity, GI irritation, and tooth/bone effects in young children
Show answer
Answer: C. hypersensitivity, cytopenias, and renal dosing concernsAn important safety issue with Piperacillin-tazobactam is hypersensitivity, cytopenias, and renal dosing concerns. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q12. A drug combines an antipseudomonal penicillin with a beta-lactamase inhibitor and is used for broad empiric treatment of serious polymicrobial infections. Which drug best matches this description?

  1. AClindamycin
  2. BCeftriaxone
  3. CGentamicin
  4. DPiperacillin-tazobactam
Show answer
Answer: D. Piperacillin-tazobactamThe description matches Piperacillin-tazobactam: it combines an antipseudomonal penicillin with a beta-lactamase inhibitor and is used for broad empiric treatment of serious polymicrobial infections.
Report a mistake

Q13. Which mechanism best explains the principal pharmacologic action of Ceftriaxone?

  1. Ainhibits bacterial cell-wall synthesis as a third-generation cephalosporin
  2. Bbinds D-Ala-D-Ala termini and inhibits cell-wall synthesis
  3. Cinhibits bacterial cell-wall synthesis as a carbapenem
  4. Dbinds the 30S ribosomal subunit and blocks aminoacyl-tRNA attachment
Show answer
Answer: A. inhibits bacterial cell-wall synthesis as a third-generation cephalosporinCeftriaxone inhibits bacterial cell-wall synthesis as a third-generation cephalosporin. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q14. Which clinical use is most appropriately associated with Ceftriaxone?

  1. Aselected gram-negative infections in patients with severe beta-lactam allergy
  2. Bmeningitis, gonorrhea, and other susceptible infections
  3. Cserious aerobic gram-negative infections and selected synergistic regimens
  4. Danaerobic infections above the diaphragm and selected gram-positive infections
Show answer
Answer: B. meningitis, gonorrhea, and other susceptible infectionsCeftriaxone is used for meningitis, gonorrhea, and other susceptible infections. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q15. Which adverse effect or toxicity is particularly important to recognize with Ceftriaxone?

  1. Anephrotoxicity and ototoxicity
  2. Bnephrotoxicity and infusion-related flushing
  3. Cbiliary sludging and hypersensitivity
  4. DQT prolongation and GI upset
Show answer
Answer: C. biliary sludging and hypersensitivityAn important safety issue with Ceftriaxone is biliary sludging and hypersensitivity. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q16. A drug inhibits bacterial cell-wall synthesis as a third-generation cephalosporin and is used for meningitis, gonorrhea, and other susceptible infections. Which drug best matches this description?

  1. ALinezolid
  2. BVancomycin
  3. CDoxycycline
  4. DCeftriaxone
Show answer
Answer: D. CeftriaxoneThe description matches Ceftriaxone: it inhibits bacterial cell-wall synthesis as a third-generation cephalosporin and is used for meningitis, gonorrhea, and other susceptible infections.
Report a mistake

Q17. Which mechanism best explains the principal pharmacologic action of Vancomycin?

  1. Abinds D-Ala-D-Ala termini and inhibits cell-wall synthesis
  2. Bbinds PBPs of aerobic gram-negative bacteria as a monobactam
  3. Cirreversibly binds the bacterial 30S ribosomal subunit
  4. Dbinds the 50S ribosomal subunit and inhibits translocation
Show answer
Answer: A. binds D-Ala-D-Ala termini and inhibits cell-wall synthesisVancomycin binds D-Ala-D-Ala termini and inhibits cell-wall synthesis. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q18. Which clinical use is most appropriately associated with Vancomycin?

  1. Aserious broad-spectrum infections
  2. Bserious gram-positive infections including MRSA
  3. Crickettsial, chlamydial, atypical, and tick-borne infections
  4. Dresistant gram-positive infections including VRE
Show answer
Answer: B. serious gram-positive infections including MRSAVancomycin is used for serious gram-positive infections including MRSA. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q19. Which adverse effect or toxicity is particularly important to recognize with Vancomycin?

  1. Aphotosensitivity, GI irritation, and tooth/bone effects in young children
  2. BGI effects and liver-enzyme elevations
  3. Cnephrotoxicity and infusion-related flushing
  4. DClostridioides difficile colitis
Show answer
Answer: C. nephrotoxicity and infusion-related flushingAn important safety issue with Vancomycin is nephrotoxicity and infusion-related flushing. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q20. A drug binds D-Ala-D-Ala termini and inhibits cell-wall synthesis and is used for serious gram-positive infections including MRSA. Which drug best matches this description?

  1. AChloramphenicol
  2. BAztreonam
  3. CAzithromycin
  4. DVancomycin
Show answer
Answer: D. VancomycinThe description matches Vancomycin: it binds D-Ala-D-Ala termini and inhibits cell-wall synthesis and is used for serious gram-positive infections including MRSA.
Report a mistake

Q21. Which mechanism best explains the principal pharmacologic action of Aztreonam?

  1. Abinds PBPs of aerobic gram-negative bacteria as a monobactam
  2. Binhibits bacterial cell-wall synthesis as a carbapenem
  3. Cbinds the 30S ribosomal subunit and blocks aminoacyl-tRNA attachment
  4. Dbinds the 50S ribosomal subunit and inhibits protein synthesis
Show answer
Answer: A. binds PBPs of aerobic gram-negative bacteria as a monobactamAztreonam binds PBPs of aerobic gram-negative bacteria as a monobactam. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q22. Which clinical use is most appropriately associated with Aztreonam?

  1. Aserious aerobic gram-negative infections and selected synergistic regimens
  2. Bselected gram-negative infections in patients with severe beta-lactam allergy
  3. Catypical respiratory infections and selected sexually transmitted infections
  4. Dlimited serious infections when safer alternatives are unsuitable
Show answer
Answer: B. selected gram-negative infections in patients with severe beta-lactam allergyAztreonam is used for selected gram-negative infections in patients with severe beta-lactam allergy. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q23. Which adverse effect or toxicity is particularly important to recognize with Aztreonam?

  1. AQT prolongation and GI upset
  2. Bseizures are uncommon but possible, especially with predisposition
  3. CGI effects and liver-enzyme elevations
  4. Dthrombocytopenia, neuropathy, and serotonin toxicity
Show answer
Answer: C. GI effects and liver-enzyme elevationsAn important safety issue with Aztreonam is GI effects and liver-enzyme elevations. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q24. A drug binds PBPs of aerobic gram-negative bacteria as a monobactam and is used for selected gram-negative infections in patients with severe beta-lactam allergy. Which drug best matches this description?

  1. ACiprofloxacin
  2. BMeropenem
  3. CClindamycin
  4. DAztreonam
Show answer
Answer: D. AztreonamThe description matches Aztreonam: it binds PBPs of aerobic gram-negative bacteria as a monobactam and is used for selected gram-negative infections in patients with severe beta-lactam allergy.
Report a mistake

Q25. Which mechanism best explains the principal pharmacologic action of Meropenem?

  1. Ainhibits bacterial cell-wall synthesis as a carbapenem
  2. Birreversibly binds the bacterial 30S ribosomal subunit
  3. Cbinds the 50S ribosomal subunit and inhibits translocation
  4. Dbinds the 50S subunit and prevents formation of the initiation complex
Show answer
Answer: A. inhibits bacterial cell-wall synthesis as a carbapenemMeropenem inhibits bacterial cell-wall synthesis as a carbapenem. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q26. Which clinical use is most appropriately associated with Meropenem?

  1. Arickettsial, chlamydial, atypical, and tick-borne infections
  2. Bserious broad-spectrum infections
  3. Canaerobic infections above the diaphragm and selected gram-positive infections
  4. Dselected gram-negative infections including Pseudomonas
Show answer
Answer: B. serious broad-spectrum infectionsMeropenem is used for serious broad-spectrum infections. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q27. Which adverse effect or toxicity is particularly important to recognize with Meropenem?

  1. AClostridioides difficile colitis
  2. Bnephrotoxicity and ototoxicity
  3. Cseizures are uncommon but possible, especially with predisposition
  4. Daplastic anemia and dose-related marrow suppression
Show answer
Answer: C. seizures are uncommon but possible, especially with predispositionAn important safety issue with Meropenem is seizures are uncommon but possible, especially with predisposition. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q28. A drug inhibits bacterial cell-wall synthesis as a carbapenem and is used for serious broad-spectrum infections. Which drug best matches this description?

  1. ATrimethoprim-sulfamethoxazole
  2. BGentamicin
  3. CLinezolid
  4. DMeropenem
Show answer
Answer: D. MeropenemThe description matches Meropenem: it inhibits bacterial cell-wall synthesis as a carbapenem and is used for serious broad-spectrum infections.
Report a mistake

Q29. Which mechanism best explains the principal pharmacologic action of Gentamicin?

  1. Airreversibly binds the bacterial 30S ribosomal subunit
  2. Bbinds the 30S ribosomal subunit and blocks aminoacyl-tRNA attachment
  3. Cbinds the 50S ribosomal subunit and inhibits protein synthesis
  4. Dinhibits bacterial peptidyl transferase on the 50S subunit
Show answer
Answer: A. irreversibly binds the bacterial 30S ribosomal subunitGentamicin irreversibly binds the bacterial 30S ribosomal subunit. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q30. Which clinical use is most appropriately associated with Gentamicin?

  1. Aatypical respiratory infections and selected sexually transmitted infections
  2. Bserious aerobic gram-negative infections and selected synergistic regimens
  3. Cresistant gram-positive infections including VRE
  4. Durinary infections, Pneumocystis treatment/prophylaxis, and selected MRSA infections
Show answer
Answer: B. serious aerobic gram-negative infections and selected synergistic regimensGentamicin is used for serious aerobic gram-negative infections and selected synergistic regimens. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q31. Which adverse effect or toxicity is particularly important to recognize with Gentamicin?

  1. Athrombocytopenia, neuropathy, and serotonin toxicity
  2. Bphotosensitivity, GI irritation, and tooth/bone effects in young children
  3. Cnephrotoxicity and ototoxicity
  4. Dtendinopathy, QT prolongation, CNS effects, and dysglycemia
Show answer
Answer: C. nephrotoxicity and ototoxicityAn important safety issue with Gentamicin is nephrotoxicity and ototoxicity. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q32. A drug irreversibly binds the bacterial 30S ribosomal subunit and is used for serious aerobic gram-negative infections and selected synergistic regimens. Which drug best matches this description?

  1. AMetronidazole
  2. BDoxycycline
  3. CChloramphenicol
  4. DGentamicin
Show answer
Answer: D. GentamicinThe description matches Gentamicin: it irreversibly binds the bacterial 30S ribosomal subunit and is used for serious aerobic gram-negative infections and selected synergistic regimens.
Report a mistake

Q33. Which mechanism best explains the principal pharmacologic action of Doxycycline?

  1. Abinds the 30S ribosomal subunit and blocks aminoacyl-tRNA attachment
  2. Bbinds the 50S ribosomal subunit and inhibits translocation
  3. Cbinds the 50S subunit and prevents formation of the initiation complex
  4. Dinhibits bacterial DNA gyrase and topoisomerase IV
Show answer
Answer: A. binds the 30S ribosomal subunit and blocks aminoacyl-tRNA attachmentDoxycycline binds the 30S ribosomal subunit and blocks aminoacyl-tRNA attachment. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q34. Which clinical use is most appropriately associated with Doxycycline?

  1. Aanaerobic infections above the diaphragm and selected gram-positive infections
  2. Brickettsial, chlamydial, atypical, and tick-borne infections
  3. Climited serious infections when safer alternatives are unsuitable
  4. Danaerobic and selected protozoal infections
Show answer
Answer: B. rickettsial, chlamydial, atypical, and tick-borne infectionsDoxycycline is used for rickettsial, chlamydial, atypical, and tick-borne infections. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q35. Which adverse effect or toxicity is particularly important to recognize with Doxycycline?

  1. Aaplastic anemia and dose-related marrow suppression
  2. BQT prolongation and GI upset
  3. Cphotosensitivity, GI irritation, and tooth/bone effects in young children
  4. Drash, hyperkalemia, marrow suppression, and kernicterus risk
Show answer
Answer: C. photosensitivity, GI irritation, and tooth/bone effects in young childrenAn important safety issue with Doxycycline is photosensitivity, GI irritation, and tooth/bone effects in young children. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q36. A drug binds the 30S ribosomal subunit and blocks aminoacyl-tRNA attachment and is used for rickettsial, chlamydial, atypical, and tick-borne infections. Which drug best matches this description?

  1. ARifampin
  2. BAzithromycin
  3. CCiprofloxacin
  4. DDoxycycline
Show answer
Answer: D. DoxycyclineThe description matches Doxycycline: it binds the 30S ribosomal subunit and blocks aminoacyl-tRNA attachment and is used for rickettsial, chlamydial, atypical, and tick-borne infections.
Report a mistake

Q37. Which mechanism best explains the principal pharmacologic action of Azithromycin?

  1. Abinds the 50S ribosomal subunit and inhibits translocation
  2. Bbinds the 50S ribosomal subunit and inhibits protein synthesis
  3. Cinhibits bacterial peptidyl transferase on the 50S subunit
  4. Dsequentially inhibits bacterial folate synthesis
Show answer
Answer: A. binds the 50S ribosomal subunit and inhibits translocationAzithromycin binds the 50S ribosomal subunit and inhibits translocation. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q38. Which clinical use is most appropriately associated with Azithromycin?

  1. Aresistant gram-positive infections including VRE
  2. Batypical respiratory infections and selected sexually transmitted infections
  3. Cselected gram-negative infections including Pseudomonas
  4. Dtuberculosis regimens and selected prophylactic indications
Show answer
Answer: B. atypical respiratory infections and selected sexually transmitted infectionsAzithromycin is used for atypical respiratory infections and selected sexually transmitted infections. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q39. Which adverse effect or toxicity is particularly important to recognize with Azithromycin?

  1. Atendinopathy, QT prolongation, CNS effects, and dysglycemia
  2. BClostridioides difficile colitis
  3. CQT prolongation and GI upset
  4. DGI upset, metallic taste, and neuropathy with prolonged use
Show answer
Answer: C. QT prolongation and GI upsetAn important safety issue with Azithromycin is QT prolongation and GI upset. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q40. A drug binds the 50S ribosomal subunit and inhibits translocation and is used for atypical respiratory infections and selected sexually transmitted infections. Which drug best matches this description?

  1. AIsoniazid
  2. BClindamycin
  3. CTrimethoprim-sulfamethoxazole
  4. DAzithromycin
Show answer
Answer: D. AzithromycinThe description matches Azithromycin: it binds the 50S ribosomal subunit and inhibits translocation and is used for atypical respiratory infections and selected sexually transmitted infections.
Report a mistake

Q41. Which mechanism best explains the principal pharmacologic action of Clindamycin?

  1. Abinds the 50S ribosomal subunit and inhibits protein synthesis
  2. Bbinds the 50S subunit and prevents formation of the initiation complex
  3. Cinhibits bacterial DNA gyrase and topoisomerase IV
  4. Dforms reactive metabolites that damage DNA in anaerobes and protozoa
Show answer
Answer: A. binds the 50S ribosomal subunit and inhibits protein synthesisClindamycin binds the 50S ribosomal subunit and inhibits protein synthesis. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q42. Which clinical use is most appropriately associated with Clindamycin?

  1. Alimited serious infections when safer alternatives are unsuitable
  2. Banaerobic infections above the diaphragm and selected gram-positive infections
  3. Curinary infections, Pneumocystis treatment/prophylaxis, and selected MRSA infections
  4. Dtreatment and prevention of tuberculosis
Show answer
Answer: B. anaerobic infections above the diaphragm and selected gram-positive infectionsClindamycin is used for anaerobic infections above the diaphragm and selected gram-positive infections. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q43. Which adverse effect or toxicity is particularly important to recognize with Clindamycin?

  1. Arash, hyperkalemia, marrow suppression, and kernicterus risk
  2. Bthrombocytopenia, neuropathy, and serotonin toxicity
  3. CClostridioides difficile colitis
  4. Dorange body fluids, hepatotoxicity, and strong enzyme induction
Show answer
Answer: C. Clostridioides difficile colitisAn important safety issue with Clindamycin is Clostridioides difficile colitis. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q44. A drug binds the 50S ribosomal subunit and inhibits protein synthesis and is used for anaerobic infections above the diaphragm and selected gram-positive infections. Which drug best matches this description?

  1. APyrazinamide
  2. BLinezolid
  3. CMetronidazole
  4. DClindamycin
Show answer
Answer: D. ClindamycinThe description matches Clindamycin: it binds the 50S ribosomal subunit and inhibits protein synthesis and is used for anaerobic infections above the diaphragm and selected gram-positive infections.
Report a mistake

Q45. Which mechanism best explains the principal pharmacologic action of Linezolid?

  1. Abinds the 50S subunit and prevents formation of the initiation complex
  2. Binhibits bacterial peptidyl transferase on the 50S subunit
  3. Csequentially inhibits bacterial folate synthesis
  4. Dinhibits DNA-dependent RNA polymerase
Show answer
Answer: A. binds the 50S subunit and prevents formation of the initiation complexLinezolid binds the 50S subunit and prevents formation of the initiation complex. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q46. Which clinical use is most appropriately associated with Linezolid?

  1. Aselected gram-negative infections including Pseudomonas
  2. Bresistant gram-positive infections including VRE
  3. Canaerobic and selected protozoal infections
  4. Dinitial multidrug treatment of tuberculosis
Show answer
Answer: B. resistant gram-positive infections including VRELinezolid is used for resistant gram-positive infections including VRE. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q47. Which adverse effect or toxicity is particularly important to recognize with Linezolid?

  1. AGI upset, metallic taste, and neuropathy with prolonged use
  2. Baplastic anemia and dose-related marrow suppression
  3. Cthrombocytopenia, neuropathy, and serotonin toxicity
  4. Dhepatotoxicity and pyridoxine-responsive peripheral neuropathy
Show answer
Answer: C. thrombocytopenia, neuropathy, and serotonin toxicityAn important safety issue with Linezolid is thrombocytopenia, neuropathy, and serotonin toxicity. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q48. A drug binds the 50S subunit and prevents formation of the initiation complex and is used for resistant gram-positive infections including VRE. Which drug best matches this description?

  1. AEthambutol
  2. BChloramphenicol
  3. CRifampin
  4. DLinezolid
Show answer
Answer: D. LinezolidThe description matches Linezolid: it binds the 50S subunit and prevents formation of the initiation complex and is used for resistant gram-positive infections including VRE.
Report a mistake

Q49. Which mechanism best explains the principal pharmacologic action of Chloramphenicol?

  1. Ainhibits bacterial peptidyl transferase on the 50S subunit
  2. Binhibits bacterial DNA gyrase and topoisomerase IV
  3. Cforms reactive metabolites that damage DNA in anaerobes and protozoa
  4. Dinhibits synthesis of mycolic acids
Show answer
Answer: A. inhibits bacterial peptidyl transferase on the 50S subunitChloramphenicol inhibits bacterial peptidyl transferase on the 50S subunit. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q50. Which clinical use is most appropriately associated with Chloramphenicol?

  1. Aurinary infections, Pneumocystis treatment/prophylaxis, and selected MRSA infections
  2. Blimited serious infections when safer alternatives are unsuitable
  3. Ctuberculosis regimens and selected prophylactic indications
  4. Dmultidrug treatment of tuberculosis
Show answer
Answer: B. limited serious infections when safer alternatives are unsuitableChloramphenicol is used for limited serious infections when safer alternatives are unsuitable. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q51. Which adverse effect or toxicity is particularly important to recognize with Chloramphenicol?

  1. Aorange body fluids, hepatotoxicity, and strong enzyme induction
  2. Btendinopathy, QT prolongation, CNS effects, and dysglycemia
  3. Caplastic anemia and dose-related marrow suppression
  4. Dhepatotoxicity and hyperuricemia
Show answer
Answer: C. aplastic anemia and dose-related marrow suppressionAn important safety issue with Chloramphenicol is aplastic anemia and dose-related marrow suppression. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q52. A drug inhibits bacterial peptidyl transferase on the 50S subunit and is used for limited serious infections when safer alternatives are unsuitable. Which drug best matches this description?

  1. APenicillin G
  2. BCiprofloxacin
  3. CIsoniazid
  4. DChloramphenicol
Show answer
Answer: D. ChloramphenicolThe description matches Chloramphenicol: it inhibits bacterial peptidyl transferase on the 50S subunit and is used for limited serious infections when safer alternatives are unsuitable.
Report a mistake

Q53. Which mechanism best explains the principal pharmacologic action of Ciprofloxacin?

  1. Ainhibits bacterial DNA gyrase and topoisomerase IV
  2. Bsequentially inhibits bacterial folate synthesis
  3. Cinhibits DNA-dependent RNA polymerase
  4. Ddisrupts mycobacterial membrane energetics after conversion to pyrazinoic acid
Show answer
Answer: A. inhibits bacterial DNA gyrase and topoisomerase IVCiprofloxacin inhibits bacterial DNA gyrase and topoisomerase IV. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q54. Which clinical use is most appropriately associated with Ciprofloxacin?

  1. Aanaerobic and selected protozoal infections
  2. Bselected gram-negative infections including Pseudomonas
  3. Ctreatment and prevention of tuberculosis
  4. Dsusceptible streptococcal and spirochetal infections
Show answer
Answer: B. selected gram-negative infections including PseudomonasCiprofloxacin is used for selected gram-negative infections including Pseudomonas. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q55. Which adverse effect or toxicity is particularly important to recognize with Ciprofloxacin?

  1. Ahepatotoxicity and pyridoxine-responsive peripheral neuropathy
  2. Brash, hyperkalemia, marrow suppression, and kernicterus risk
  3. Ctendinopathy, QT prolongation, CNS effects, and dysglycemia
  4. Doptic neuritis with impaired red-green discrimination
Show answer
Answer: C. tendinopathy, QT prolongation, CNS effects, and dysglycemiaAn important safety issue with Ciprofloxacin is tendinopathy, QT prolongation, CNS effects, and dysglycemia. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q56. A drug inhibits bacterial DNA gyrase and topoisomerase IV and is used for selected gram-negative infections including Pseudomonas. Which drug best matches this description?

  1. AAmoxicillin
  2. BTrimethoprim-sulfamethoxazole
  3. CPyrazinamide
  4. DCiprofloxacin
Show answer
Answer: D. CiprofloxacinThe description matches Ciprofloxacin: it inhibits bacterial DNA gyrase and topoisomerase IV and is used for selected gram-negative infections including Pseudomonas.
Report a mistake

Q57. Which mechanism best explains the principal pharmacologic action of Trimethoprim-sulfamethoxazole?

  1. Asequentially inhibits bacterial folate synthesis
  2. Bforms reactive metabolites that damage DNA in anaerobes and protozoa
  3. Cinhibits synthesis of mycolic acids
  4. Dinhibits arabinosyl transferase and cell-wall arabinogalactan synthesis
Show answer
Answer: A. sequentially inhibits bacterial folate synthesisTrimethoprim-sulfamethoxazole sequentially inhibits bacterial folate synthesis. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q58. Which clinical use is most appropriately associated with Trimethoprim-sulfamethoxazole?

  1. Atuberculosis regimens and selected prophylactic indications
  2. Burinary infections, Pneumocystis treatment/prophylaxis, and selected MRSA infections
  3. Cinitial multidrug treatment of tuberculosis
  4. Dsusceptible respiratory and other community infections
Show answer
Answer: B. urinary infections, Pneumocystis treatment/prophylaxis, and selected MRSA infectionsTrimethoprim-sulfamethoxazole is used for urinary infections, Pneumocystis treatment/prophylaxis, and selected MRSA infections. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q59. Which adverse effect or toxicity is particularly important to recognize with Trimethoprim-sulfamethoxazole?

  1. Ahepatotoxicity and hyperuricemia
  2. BGI upset, metallic taste, and neuropathy with prolonged use
  3. Crash, hyperkalemia, marrow suppression, and kernicterus risk
  4. Dhypersensitivity reactions and seizures at very high exposure
Show answer
Answer: C. rash, hyperkalemia, marrow suppression, and kernicterus riskAn important safety issue with Trimethoprim-sulfamethoxazole is rash, hyperkalemia, marrow suppression, and kernicterus risk. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q60. A drug sequentially inhibits bacterial folate synthesis and is used for urinary infections, Pneumocystis treatment/prophylaxis, and selected MRSA infections. Which drug best matches this description?

  1. APiperacillin-tazobactam
  2. BMetronidazole
  3. CEthambutol
  4. DTrimethoprim-sulfamethoxazole
Show answer
Answer: D. Trimethoprim-sulfamethoxazoleThe description matches Trimethoprim-sulfamethoxazole: it sequentially inhibits bacterial folate synthesis and is used for urinary infections, Pneumocystis treatment/prophylaxis, and selected MRSA infections.
Report a mistake